Literature DB >> 8573504

Sutterella wadsworthensis gen. nov., sp. nov., bile-resistant microaerophilic Campylobacter gracilis-like clinical isolates.

H M Wexler1, D Reeves, P H Summanen, E Molitoris, M McTeague, J Duncan, K H Wilson, S M Finegold.   

Abstract

Campylobacter gracilis (formerly Bacteroides gracilis) is an asaccharolytic, nitrate-positive, urease-negative organism that requires formate and fumarate or hydrogen as a growth additive and may pit agar media. Clinical isolates that were obtained primarily from appendiceal and peritoneal fluid specimens and initially were identified in our laboratory as B. gracilis were later found to include "unusual" strains that could be distinguished by biochemical and genetic criteria. These unusual C. gracilis strains were bile resistant, could not reduce tetrazolium chloride under aerobic conditions if formate and fumarate were added to the medium, and could grow in the presence of 2 or 6% oxygen if no blood was added to the medium. C. gracilis, other campylobacters, and the unusual strains produced distinctive dehydrogenase patterns when gels were incubated anaerobically. A cellular fatty acid analysis revealed that the cluster formed by the unusual organisms was distinct from the (separate) clusters formed by C. gracilis, Bacteroides ureolyticus, and other Campylobacter species. 16S rRNA sequence data indicated that these organisms are not related phylogenetically to either C. gracilis or other Campylobacter species; the most closely related taxa as determined by rRNA sequence analysis were unrelated aerobes (members of the genera Bordetella, Alcaligenes, Rhodocyclus, and Comamonas). DNA homology data confirmed that these taxa are separate groups. Our data indicate that the unusual organisms are members of a new genus and new species, for which we propose the name Sutterella wadsworthensis. The type strain of S. wadsworthensis is strain WAL 9799 (= ATCC 51579).

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8573504     DOI: 10.1099/00207713-46-1-252

Source DB:  PubMed          Journal:  Int J Syst Bacteriol        ISSN: 0020-7713


  24 in total

1.  In vitro activities of MK-826 (L-749,345) against 363 strains of anaerobic bacteria.

Authors:  H M Wexler; D Molitoris; S M Finegold
Journal:  Antimicrob Agents Chemother       Date:  2000-08       Impact factor: 5.191

2.  Sydney M. Finegold.

Authors: 
Journal:  J Clin Microbiol       Date:  2012-05-23       Impact factor: 5.948

3.  Correlation between intraluminal oxygen gradient and radial partitioning of intestinal microbiota.

Authors:  Lindsey Albenberg; Tatiana V Esipova; Colleen P Judge; Kyle Bittinger; Jun Chen; Alice Laughlin; Stephanie Grunberg; Robert N Baldassano; James D Lewis; Hongzhe Li; Stephen R Thom; Frederic D Bushman; Sergei A Vinogradov; Gary D Wu
Journal:  Gastroenterology       Date:  2014-07-18       Impact factor: 22.682

4.  Genetic diversity of viable, injured, and dead fecal bacteria assessed by fluorescence-activated cell sorting and 16S rRNA gene analysis.

Authors:  Kaouther Ben-Amor; Hans Heilig; Hauke Smidt; Elaine E Vaughan; Tjakko Abee; Willem M de Vos
Journal:  Appl Environ Microbiol       Date:  2005-08       Impact factor: 4.792

5.  Prevalence of Campylobacter, Arcobacter, Helicobacter, and Sutterella spp. in human fecal samples as estimated by a reevaluation of isolation methods for Campylobacters.

Authors:  J Engberg; S L On; C S Harrington; P Gerner-Smidt
Journal:  J Clin Microbiol       Date:  2000-01       Impact factor: 5.948

6.  In vitro activities of trovafloxacin against 557 strains of anaerobic bacteria.

Authors:  H M Wexler; E Molitoris; D Molitoris; S M Finegold
Journal:  Antimicrob Agents Chemother       Date:  1996-09       Impact factor: 5.191

7.  "Bacteroides goldsteinii sp. nov." isolated from clinical specimens of human intestinal origin.

Authors:  Yuli Song; Chengxu Liu; Julia Lee; Mauricio Bolanos; Marja-Liisa Vaisanen; Sydney M Finegold
Journal:  J Clin Microbiol       Date:  2005-09       Impact factor: 5.948

8.  In vitro activities of faropenem against 579 strains of anaerobic bacteria.

Authors:  Hannah M Wexler; Denise Molitoris; Shahera St John; Ann Vu; Erik K Read; Sydney M Finegold
Journal:  Antimicrob Agents Chemother       Date:  2002-11       Impact factor: 5.191

9.  Sutterella faecalis sp. nov., isolated from human faeces.

Authors:  Byeong Seob Oh; Ji-Sun Kim; Seung Yeob Yu; Seoung Woo Ryu; Seung-Hwan Park; Se Won Kang; Jam-Eon Park; Seung-Hyeon Choi; Kook-Il Han; Keun Chul Lee; Mi Kyung Eom; Min Kuk Suh; Han Sol Kim; Dong Ho Lee; Hyuk Yoon; Byung-Yong Kim; Je Hee Lee; Jung-Sook Lee; Ju Huck Lee
Journal:  J Microbiol       Date:  2020-01-29       Impact factor: 3.422

10.  "Bacteroides nordii" sp. nov. and "Bacteroides salyersae" sp. nov. isolated from clinical specimens of human intestinal origin.

Authors:  Y L Song; C X Liu; M McTeague; S M Finegold
Journal:  J Clin Microbiol       Date:  2004-12       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.